A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Migraine Headache Brain Diseases Central Nervous System Diseases Headache Headache Disorders Headache Disorders, Primary Migraine Disorders Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kern Medical Center

Bakersfield, California, 93305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Meets IHS criteria for migraine

Exclusion criteria

Pregnant
Breast feeding
Allergic to Lidocaine
Worst or first Headache
Abnormal neurological exam
Substance abuse within 6 months
Cardiac, liver or pulmonary disease
Participation n another study within 30 days

Treatment and study plan

Lidocaine

Drug

Primary outcomes

Resolution of symptoms

Secondary outcomes

Improvement in 10 point pain score

Sponsors and collaborators

Lead sponsor

Kern Medical Center

Other

Registry information

Important dates

Study start: 2002
Study completion: 2006
First posted: Feb 7, 2006
Registry last updated: Jan 25, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed